Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jones T Nauseef

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
NPJ Precision Oncology|March 29, 2025
A complex phylogeny of lineage plasticity in metastatic castration resistant prostate cancerJones T Nauseef, Timothy R Chu, William F Hooper, et al.
JNCI Cancer Spectrum|June 3, 2022
The Impact of Androgen Deprivation Therapy on COVID-19 Illness in Men With Prostate CancerNeil J Shah, Vaibhav G Patel, Xiaobo Zhong, et al.
The Oncologist|October 22, 2025
Genomic Alterations and Associated Outcomes in Patients with PSMA-Positive Metastatic Castration-Resistant Prostate Cancer treated with 177Lu-PSMA-617Justine Panian, Nicholas C Henderson, Daniel Herchenhorn, et al.
JCO Precision Oncology|December 5, 2025
Impact of <i>SPOP</i> Mutations on Clinical Outcomes in Metastatic Prostate CancerDeepak Kilari, Nicholas C Henderson, Kyra Yamamoto, et al.
European Urology Oncology|June 10, 2025
A Randomized Controlled Phase 2 Trial Comparing Salvage Radiotherapy for Prostate Cancer Delivered in 4 Versus 2 Weeks (SHORTER): Acute Genitourinary and Gastrointestinal Patient-reported Outcomes at a Single InstitutionHimanshu Nagar, Marshall A Diven, Brady Rippon, et al.
Medrxiv : the Preprint Server for Health Sciences|July 9, 2025
Genomic alterations in the YAP/TAZ pathway are associated with stem cell-like castration-resistant prostate cancerMarjorie L Roskes, Alexander Martinez-Fundichely, Sandra Cohen, et al.
Nature|October 9, 2024
The interplay of mutagenesis and ecDNA shapes urothelial cancer evolutionDuy D Nguyen, William F Hooper, Weisi Liu, et al.
Science Advances|June 26, 2026
Patient-derived organoids across cancers reveal conserved tumor heterogeneity and actionable therapeutic vulnerabilitiesHui-Hsuan Kuo, Bhavneet Bhinder, Hamza N Gokozan, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
NPJ Precision Oncology|March 29, 2025
A complex phylogeny of lineage plasticity in metastatic castration resistant prostate cancerJones T Nauseef, Timothy R Chu, William F Hooper, et al.
JNCI Cancer Spectrum|June 3, 2022
The Impact of Androgen Deprivation Therapy on COVID-19 Illness in Men With Prostate CancerNeil J Shah, Vaibhav G Patel, Xiaobo Zhong, et al.
The Oncologist|October 22, 2025
Genomic Alterations and Associated Outcomes in Patients with PSMA-Positive Metastatic Castration-Resistant Prostate Cancer treated with 177Lu-PSMA-617Justine Panian, Nicholas C Henderson, Daniel Herchenhorn, et al.
JCO Precision Oncology|December 5, 2025
Impact of <i>SPOP</i> Mutations on Clinical Outcomes in Metastatic Prostate CancerDeepak Kilari, Nicholas C Henderson, Kyra Yamamoto, et al.
European Urology Oncology|June 10, 2025
A Randomized Controlled Phase 2 Trial Comparing Salvage Radiotherapy for Prostate Cancer Delivered in 4 Versus 2 Weeks (SHORTER): Acute Genitourinary and Gastrointestinal Patient-reported Outcomes at a Single InstitutionHimanshu Nagar, Marshall A Diven, Brady Rippon, et al.
Medrxiv : the Preprint Server for Health Sciences|July 9, 2025
Genomic alterations in the YAP/TAZ pathway are associated with stem cell-like castration-resistant prostate cancerMarjorie L Roskes, Alexander Martinez-Fundichely, Sandra Cohen, et al.
Nature|October 9, 2024
The interplay of mutagenesis and ecDNA shapes urothelial cancer evolutionDuy D Nguyen, William F Hooper, Weisi Liu, et al.
Science Advances|June 26, 2026
Patient-derived organoids across cancers reveal conserved tumor heterogeneity and actionable therapeutic vulnerabilitiesHui-Hsuan Kuo, Bhavneet Bhinder, Hamza N Gokozan, et al.
Pageof 3